Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

ConferenceMedicine and clinical research · Abu Dhabi, United Arab Emirates

5th Emirates Pediatric Bone Marrow Transplant and Gene Therapy Congress

The 5th Emirates Pediatric Bone Marrow Transplant and Gene Therapy Congress, held in Abu Dhabi on 24 and 25 April 2027, is a regional congress on paediatric haematopoietic stem cell transplantation and gene therapy. This guide covers topic areas consistent with that scope, checks before submitting, what reviewers typically value and how to prepare an abstract before the 31 December 2026 deadline.

Pubrica InsightsEditorial team, reviewed by a subject specialist
Next deadline
31 December 2026
Last checked
10 November 2026
Organiser
Emirates Pediatric Bone Marrow Transplant Congress organising committee
Sources
1
Submit an abstract

Key dates

Abstract deadline
31 December 2026
Full paper deadline
Abstracts only, or not stated
Conference dates
24 April 2027 – 25 April 2027
Details last checked
10 November 2026
Submit an abstract

About the conference

Conference
5th Emirates Pediatric Bone Marrow Transplant and Gene Therapy Congress
Organiser
Emirates Pediatric Bone Marrow Transplant Congress organising committee
Venue
Abu Dhabi, United Arab Emirates
Scope
Regional congress on paediatric haematopoietic stem cell transplantation and gene therapy, inviting abstracts until 31 December 2026.
Submission types
Abstracts; confirm formats and word limits on the official page

Topics consistent with the programme

  • Outcomes of paediatric haematopoietic stem cell transplantation for malignant and non-malignant diseases
  • Gene therapy approaches for inherited blood and immune disorders in children
  • Donor selection, conditioning regimens and graft engineering in paediatric transplantation
  • Prevention and management of graft-versus-host disease and transplant infections
  • Long-term follow-up, survivorship and quality of life after transplantation
  • Transplant services and access to care in the Middle East region

Based on the published scope; the official page sets out the full themes and requirements.

Is your work a fit? Check before you submit

  1. Confirm the work concerns paediatric stem cell transplantation, gene therapy or closely related care.
  2. Check that the results or experience reported are original and clearly described.
  3. Describe the patient population, methods and outcomes in sufficient detail.
  4. Confirm abstract categories and format rules on the official call for abstracts page.
  5. Submit a complete, co-author-approved abstract before 31 December 2026.

Why This Conference Matters

Haematopoietic stem cell transplantation remains a curative option for many children with malignant and inherited disorders, and gene therapy is creating new possibilities for some of these conditions. Outcomes depend on donor availability, supportive care and long-term follow-up, which vary across regions. A regional congress allows clinicians and researchers to share experience from their own centres, compare practice and discuss how advances in transplantation and gene therapy can be delivered to children in the region.

Who Should Submit

Academic backgrounds

  • Paediatric haematology and oncology
  • Stem cell transplantation
  • Immunology
  • Gene and cell therapy
  • Paediatric infectious diseases

Institutions and sectors

  • Children’s hospitals and transplant centres
  • University medical centres
  • Cell and gene therapy companies

What Reviewers Typically Value

  1. Centre-level outcome data that add to evidence on paediatric transplantation in the region.
  2. Clinical experience with new therapies described clearly enough to inform other teams.
  3. Studies of complications and supportive care that suggest practical improvements.
  4. Work addressing access, equity or long-term follow-up for transplanted children.

Ideas You Could Develop

Single-centre transplant outcomesAn abstract reporting survival and complications in children transplanted for thalassaemia or other inherited disorders at one centre.
Viral infections after transplantationA review of monitoring and management of viral reactivation in a paediatric transplant cohort.
Survivorship clinic experienceA description of a long-term follow-up programme for children after transplantation and the late effects identified.

Your Plan to the Deadline

A suggested schedule working back from 31 December 2026. Adjust it to the stage your work has reached.

  1. By 19 Nov 2026

    Open the official call for abstracts; confirm the tracks, word limit, format and author rules.

  2. By 3 Dec 2026

    Agree the key result, the authors and the presenting author.

  3. By 17 Dec 2026

    Draft the structured abstract to the word limit, with results stated as numbers.

  4. By 24 Dec 2026

    Circulate to co-authors and an independent reader; revise.

  5. By 29 Dec 2026

    Final checks: title, author affiliations, conflicts of interest and track selection.

  6. By 31 Dec 2026

    Submit through the official abstract system before the deadline.

What you gain

  • Feedback from peers working on the same questions.
  • A citable abstract or proceedings paper.
  • Contacts for collaboration, employment and future funding.
  • A step towards a full journal article.

What happens after you submit

  1. Acknowledgement: the abstract system confirms receipt; keep the submission number.
  2. Review: the scientific committee scores abstracts against the track criteria.
  3. Decision: accepted abstracts are assigned to an oral, poster or e-poster session.
  4. Registration: presenting authors usually must register by a stated date.
  5. Publication: accepted abstracts or papers may appear in the conference proceedings or journal supplement.

What the Organisers Are Looking For

The congress is looking for abstracts on paediatric haematopoietic stem cell transplantation and gene therapy, including clinical outcomes, complications, supportive care and service development. Strong submissions typically report original data or experience with a clear objective and well-described methods. Abstract categories, format requirements and presentation options should be confirmed on the official call for abstracts page of the congress website.

Read the official pageThis guide summarises the opportunity. Confirm deadlines, eligibility and requirements on the official page before you plan your work, and record the date you checked it.Open the official page

FAQs

Questions Researchers Ask

The next published deadline is 31 December 2026. Dates can change, so confirm them on the official page before you plan your work.

Regional congresses sometimes accept case reports where they offer clear clinical lessons, but this is not guaranteed. Check the accepted abstract types on the official call for abstracts page before preparing a submission.

The official page lists abstract submission; check it for any full paper or proceedings option.

Yes. Pubrica’s specialists can review, write, edit and format your abstract, paper, poster or slides. You remain the author and the person responsible for the submission.

Sources

  1. Emirates Pediatric Bone Marrow Transplant Congress organising committee. (2026). 5th Emirates Pediatric Bone Marrow Transplant and Gene Therapy Congress. Retrieved 10 November 2026, from https://epbmtc.ae/call-for-abstracts/

How to cite this page

Pubrica Insights. (2026). 5th Emirates Pediatric Bone Marrow Transplant and Gene Therapy Congress. Pubrica. https://pubrica.com/insights/calls-and-conferences/5th-emirates-pediatric-bone-marrow-transplant-and-gene-therapy-congres/

EPBMT 2027Next deadline 31 December 2026

Official page
Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.